Natraj Proteins sets 35th AGM for September 29, 2026

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Natraj Proteins holds its 35th AGM on September 29, 2026
  • The meeting occurs via Video Conferencing at 2:00 pm
  • Book closure runs from September 23 to September 29, 2026
  • Filing complies with Section 91 of the Companies Act, 2013
powered bylight_fuzz_icon
50080642

*this image is generated using AI for illustrative purposes only.

Natraj Proteins has scheduled its 35th Annual General Meeting for Tuesday, September 29, 2026. The company will hold the meeting through Video Conferencing or Other Audio-Visual Means at 2:00 pm.

The Register of Members and share transfer books will remain closed from September 23, 2026, to September 29, 2026, inclusive of both days. This book closure is required under Section 91 of the Companies Act, 2013.

Meeting Details

The meeting aligns with circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The company submitted the intimation to the Bombay Stock Exchange on September 4, 2026.

Security Type Book Closure Period Purpose
Equity Shares September 23, 2026 to September 29, 2026 Annual Book Closure

Harshita Kirkire, Company Secretary and Compliance Officer, signed the filing.

Historical Stock Returns for Natraj Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.86%+6.61%+16.08%+42.24%+4.06%-51.09%

What key financial results or strategic initiatives is Natraj Proteins expected to present at the upcoming AGM?

How might the proposed dividend payout, if any, impact the stock's valuation and investor sentiment post-meeting?

Are there any anticipated changes to the board of directors or executive management during this annual meeting?

Natraj Proteins returns to profit in FY26

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Natraj Proteins Limited reported a net profit of ₹113.51 lakh for FY26, reversing the previous year's loss of ₹146.27 lakh. Annual income from operations stood at ₹10112.13 lakh, while Q4 profit was ₹110.84 lakh on revenue of ₹1887.26 lakh.

powered bylight_fuzz_icon
41167514

*this image is generated using AI for illustrative purposes only.

Natraj Proteins Limited has announced its audited financial results for the year ended March 31, 2026, reporting a return to profitability. The company recorded a net profit of ₹113.51 lakh for the full fiscal year, a significant turnaround from the net loss of ₹146.27 lakh posted in the previous year ended March 31, 2025.

The board of directors approved the financial results during a meeting held on May 22, 2026. Total income from operations for FY26 stood at ₹10112.13 lakh, a decrease from the ₹11778.29 lakh reported in the prior year. Despite the lower revenue, improved cost management and operational efficiency contributed to the positive bottom line.

Financial Performance

The company's paid-up equity share capital remained constant at ₹374.70 lakh with a face value of ₹10 per share. Reserves, excluding revaluation reserve, increased to ₹2959.03 lakh as of March 31, 2026, compared to ₹2848.00 lakh in the previous year.

For the fourth quarter ended March 31, 2026, Natraj Proteins reported a net profit of ₹110.84 lakh. Total income for the quarter was ₹1887.26 lakh. The earnings per share (EPS) for the year improved to ₹3.03 from a negative ₹3.9 in the previous year.

Key Financial Metrics

Particulars Year Ended 31.03.2026 (Audited) Year Ended 31.03.2025 (Audited)
Total income from operations ₹10112.13 lakh ₹11778.29 lakh
Net Profit for the period ₹113.51 lakh ₹-146.27 lakh
Paid up Equity Share Capital ₹374.70 lakh ₹374.70 lakh
Reserves ₹2959.03 lakh ₹2848.00 lakh
Basic EPS ₹3.03 ₹(3.9)

The detailed financial results are available on the company's website and the BSE platform.

Historical Stock Returns for Natraj Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.86%+6.61%+16.08%+42.24%+4.06%-51.09%

What specific cost management strategies did Natraj Proteins implement in FY26, and are these measures sustainable enough to maintain profitability despite declining revenues in FY27?

Will Natraj Proteins announce a dividend for FY26 given the return to profitability, and how might this impact investor sentiment toward the stock?

What is driving the ~14% decline in revenue from operations, and does management have a concrete plan to reverse this downward trend in FY27?

More News on Natraj Proteins

1 Year Returns:+4.06%